WO1997014783B1 - Tissue-engineered bone repair using cultured periosteal cells - Google Patents
Tissue-engineered bone repair using cultured periosteal cellsInfo
- Publication number
- WO1997014783B1 WO1997014783B1 PCT/US1996/016664 US9616664W WO9714783B1 WO 1997014783 B1 WO1997014783 B1 WO 1997014783B1 US 9616664 W US9616664 W US 9616664W WO 9714783 B1 WO9714783 B1 WO 9714783B1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cells
- matrix
- composition
- periosteal
- bone
- Prior art date
Links
- 210000000988 Bone and Bones Anatomy 0.000 title claims 8
- 239000011159 matrix material Substances 0.000 claims 11
- 239000000203 mixture Substances 0.000 claims 11
- 230000001939 inductive effect Effects 0.000 claims 5
- 102000004190 Enzymes Human genes 0.000 claims 4
- 108090000790 Enzymes Proteins 0.000 claims 4
- 230000002708 enhancing Effects 0.000 claims 4
- 230000011164 ossification Effects 0.000 claims 4
- 239000000411 inducer Substances 0.000 claims 3
- 210000001519 tissues Anatomy 0.000 claims 3
- XEYBRNLFEZDVAW-ARSRFYASSA-N (5Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoic acid Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O XEYBRNLFEZDVAW-ARSRFYASSA-N 0.000 claims 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N Cortisol Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 claims 2
- 229960003957 Dexamethasone Drugs 0.000 claims 2
- UREBDLICKHMUKA-CXSFZGCWSA-N Dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 claims 2
- 229960002061 Ergocalciferol Drugs 0.000 claims 2
- 229940082622 Prostaglandin cardiac therapy preparations Drugs 0.000 claims 2
- 229940077717 Prostaglandin drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD) Drugs 0.000 claims 2
- 229940029983 VITAMINS Drugs 0.000 claims 2
- 229930003268 Vitamin C Natural products 0.000 claims 2
- 229940046008 Vitamin D Drugs 0.000 claims 2
- 229930003316 Vitamin D Natural products 0.000 claims 2
- 229940021016 Vitamin IV solution additives Drugs 0.000 claims 2
- 238000006065 biodegradation reaction Methods 0.000 claims 2
- 230000002308 calcification Effects 0.000 claims 2
- 229960002986 dinoprostone Drugs 0.000 claims 2
- 229960000890 hydrocortisone Drugs 0.000 claims 2
- 239000000017 hydrogel Substances 0.000 claims 2
- 229910052588 hydroxylapatite Inorganic materials 0.000 claims 2
- 238000002513 implantation Methods 0.000 claims 2
- 239000000463 material Substances 0.000 claims 2
- 229920005615 natural polymer Polymers 0.000 claims 2
- 229940094443 oxytocics Prostaglandins Drugs 0.000 claims 2
- OAICVXFJPJFONN-UHFFFAOYSA-N phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims 2
- 229910052698 phosphorus Inorganic materials 0.000 claims 2
- 239000011574 phosphorus Substances 0.000 claims 2
- 150000003180 prostaglandins Chemical class 0.000 claims 2
- 150000003431 steroids Chemical class 0.000 claims 2
- 229920001059 synthetic polymer Polymers 0.000 claims 2
- 235000013343 vitamin Nutrition 0.000 claims 2
- 239000011782 vitamin Substances 0.000 claims 2
- 235000019154 vitamin C Nutrition 0.000 claims 2
- 239000011718 vitamin C Substances 0.000 claims 2
- 150000003700 vitamin C derivatives Chemical class 0.000 claims 2
- 235000019166 vitamin D Nutrition 0.000 claims 2
- 239000011710 vitamin D Substances 0.000 claims 2
- 150000003710 vitamin D derivatives Chemical class 0.000 claims 2
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 claims 2
- 235000001892 vitamin D2 Nutrition 0.000 claims 2
- 239000011653 vitamin D2 Substances 0.000 claims 2
- 229930003231 vitamins Natural products 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 claims 1
- 230000004069 differentiation Effects 0.000 claims 1
- 239000001963 growth media Substances 0.000 claims 1
- 238000000338 in vitro Methods 0.000 claims 1
- 239000002609 media Substances 0.000 claims 1
- 239000000758 substrate Substances 0.000 claims 1
- 229920002683 Glycosaminoglycan Polymers 0.000 abstract 1
- 102000004067 Osteocalcin Human genes 0.000 abstract 1
- 108090000573 Osteocalcin Proteins 0.000 abstract 1
- 238000010256 biochemical assay Methods 0.000 abstract 1
- 238000004113 cell culture Methods 0.000 abstract 1
- 239000007943 implant Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000001582 osteoblastic Effects 0.000 abstract 1
Abstract
Periosteal cells have been grown in cell culture and have been shown to have an osteoblastic phenotype, with production of osteocalcin and glycosaminoglycan. When seeded into polymeric implants, repair of critical size cranial defects was demonstrated and was confirmed by histology, biochemical assays, and radiodensitometry.
Claims
AMENDED CLAIMS
[received by the International Bureau on 10 April 1997 (1004.97), original claims 1-15 replaced by amended claims 1-15 (2 pages)]
1 A method for making a composition for repair of bone defects consisting essentially of obtaining periosteal tissue, dissociating the cells in the periosteal tissue, and culturing the cells on and in a biocompatible matrix suitable for repair of the defect under conditions inducing the periosteal cells to form bone
2 The method of claim 1 wherein the matrix is formed of a material selected from the group consisting of hydroxyapatite, synthetic polymers, natural polymers, and mixtures thereof
3 The method of claim 1 wherein the matrix is biodegradable
4 The method of claim 1 wherein the matrix is a hydrogel
5 The method of claim 1 wherein the matrix in combination with the implantation substrate induce the periosteal cells to differentiate into bone
6 The method of claim 1 wherein the cells are cultured in vitro prior to implantation under conditions inducing differentiation of the periosteal cells into bone
7 The method of claim 6 wherein the periosteal cells are cultured in media comprising inducers of osteogenesis selected from the group consisting of steroids inducing bone formation, enzymes enhancing calcification, enzymes enhancing phosphorus deposition, vitamins, and prostaglandins
8 The method of claim 7 wherein the inducers are selected from the group consisting of dexamethasone, calciferol, cortisol, vitamin C, vitamin D, and prostaglandin E2
9 A composition for repair of bone defects consisting essentially of cells obtained by dissociating periosteal tissue, wherein the cells are seeded on and in a biocompatible matrix suitable for repair of the defect, and culture conditions inducing the periosteal cells to form bone
10. The composition of claim 9 wherein Lhe matrix is formed of a material selected from the group consisting of hydroxyapatite, synthetic polymers, natural polymers, and mixtures thereof.
11. The composition of claim 9 wherein the matrix is biodegradable.
12. The composition of claim 10 wherein the matrix is a hydrogel.
13. The composition of claim 9 wherein the matrix induces the periosteal cells to differentiate into bone.
14. The composition of claim 9 wherein the periosteal cells are cultured on the matrix in a culture media comprising inducers of osteogenesis selected from the group consisting of steroids inducing bone formation, enzymes enhancing calcification, enzymes enhancing phosphorus deposition, vitamins, and prostaglandins.
15. The composition of claim 14 wherein the compounds are selected from the group consisting of dexamethasone, calciferol, cortisol, vitamin C, vitamin D, and prostaglandin E2.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU74515/96A AU7451596A (en) | 1995-10-20 | 1996-10-17 | Tissue-engineered bone repair using cultured periosteal cells |
| EP96936643A EP0862617A1 (en) | 1995-10-20 | 1996-10-17 | Tissue-engineered bone repair using cultured periosteal cells |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US545,988 | 1990-06-28 | ||
| US08/545,988 US5700289A (en) | 1995-10-20 | 1995-10-20 | Tissue-engineered bone repair using cultured periosteal cells |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO1997014783A1 WO1997014783A1 (en) | 1997-04-24 |
| WO1997014783B1 true WO1997014783B1 (en) | 1997-05-22 |
Family
ID=24178377
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US1996/016664 WO1997014783A1 (en) | 1995-10-20 | 1996-10-17 | Tissue-engineered bone repair using cultured periosteal cells |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US5700289A (en) |
| EP (1) | EP0862617A1 (en) |
| AU (1) | AU7451596A (en) |
| WO (1) | WO1997014783A1 (en) |
Families Citing this family (127)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030077825A1 (en) * | 1994-07-22 | 2003-04-24 | Bhatnagar Rajendra S. | Structures useful for bone engineering and methods |
| US7968110B2 (en) * | 1992-02-11 | 2011-06-28 | Merz Aesthetics, Inc. | Tissue augmentation material and method |
| US6537574B1 (en) * | 1992-02-11 | 2003-03-25 | Bioform, Inc. | Soft tissue augmentation material |
| US7060287B1 (en) * | 1992-02-11 | 2006-06-13 | Bioform Inc. | Tissue augmentation material and method |
| US6027742A (en) | 1995-05-19 | 2000-02-22 | Etex Corporation | Bioresorbable ceramic composites |
| US6132463A (en) * | 1995-05-19 | 2000-10-17 | Etex Corporation | Cell seeding of ceramic compositions |
| US5676976A (en) | 1995-05-19 | 1997-10-14 | Etex Corporation | Synthesis of reactive amorphous calcium phosphates |
| US6541037B1 (en) | 1995-05-19 | 2003-04-01 | Etex Corporation | Delivery vehicle |
| US6287341B1 (en) | 1995-05-19 | 2001-09-11 | Etex Corporation | Orthopedic and dental ceramic implants |
| US5824084A (en) * | 1996-07-03 | 1998-10-20 | The Cleveland Clinic Foundation | Method of preparing a composite bone graft |
| DE19630034A1 (en) * | 1996-07-25 | 1998-04-23 | Huels Chemische Werke Ag | Biohybrid dental implant |
| US6953594B2 (en) | 1996-10-10 | 2005-10-11 | Etex Corporation | Method of preparing a poorly crystalline calcium phosphate and methods of its use |
| US7517539B1 (en) | 1996-10-16 | 2009-04-14 | Etex Corporation | Method of preparing a poorly crystalline calcium phosphate and methods of its use |
| US8728536B2 (en) | 1996-10-16 | 2014-05-20 | Etex Corporation | Chemotherapeutic composition using nanocrystalline calcium phosphate paste |
| DE69738398T2 (en) | 1996-10-16 | 2008-12-04 | Etex Corp., Cambridge | BIOKERAMIC COMPOSITION |
| US5866415A (en) * | 1997-03-25 | 1999-02-02 | Villeneuve; Peter E. | Materials for healing cartilage and bone defects |
| US5981826A (en) * | 1997-05-05 | 1999-11-09 | Georgia Tech Research Corporation | Poly(vinyl alcohol) cryogel |
| US20030008396A1 (en) * | 1999-03-17 | 2003-01-09 | Ku David N. | Poly(vinyl alcohol) hydrogel |
| US6077987A (en) * | 1997-09-04 | 2000-06-20 | North Shore-Long Island Jewish Research Institute | Genetic engineering of cells to enhance healing and tissue regeneration |
| DE19803673A1 (en) * | 1998-01-30 | 1999-08-05 | Norbert M Dr Meenen | Biohybrid joint replacement |
| CA2320136A1 (en) * | 1998-02-10 | 1999-08-12 | Oregon Health Sciences University | Treatment of bony defects with osteoblast precursor cells |
| US7019192B2 (en) * | 1998-02-27 | 2006-03-28 | Musculoskeletal Transplant Foundation | Composition for filling bone defects |
| US6821462B2 (en) * | 1998-07-10 | 2004-11-23 | Jeneric/Pentron, Inc. | Mass production of shells and models for dental restorations produced by solid free-form fabrication methods |
| US6808659B2 (en) | 1998-07-10 | 2004-10-26 | Jeneric/Pentron Incorporated | Solid free-form fabrication methods for the production of dental restorations |
| US20050023710A1 (en) * | 1998-07-10 | 2005-02-03 | Dmitri Brodkin | Solid free-form fabrication methods for the production of dental restorations |
| US6322728B1 (en) | 1998-07-10 | 2001-11-27 | Jeneric/Pentron, Inc. | Mass production of dental restorations by solid free-form fabrication methods |
| US6551355B1 (en) | 1998-08-14 | 2003-04-22 | Cambridge Scientific, Inc. | Tissue transplant coated with biocompatible biodegradable polymer |
| US6197061B1 (en) | 1999-03-01 | 2001-03-06 | Koichi Masuda | In vitro production of transplantable cartilage tissue cohesive cartilage produced thereby, and method for the surgical repair of cartilage damage |
| US6143030A (en) * | 1999-03-26 | 2000-11-07 | Bristol-Myers Squibb Co. | Impaction allograft form and method of orthopaedic surgery using same |
| US7371408B1 (en) * | 1999-06-07 | 2008-05-13 | Wright Medical Technology, Inc. | Bone graft substitute composition |
| FR2794982B1 (en) * | 1999-06-15 | 2001-08-03 | Depuy Bioland | BONE GRAFT MATERIAL FORMED FROM A PHOSPHOCALCIC CERAMIC AND BONE TISSUE |
| US6521431B1 (en) * | 1999-06-22 | 2003-02-18 | Access Pharmaceuticals, Inc. | Biodegradable cross-linkers having a polyacid connected to reactive groups for cross-linking polymer filaments |
| US6303138B1 (en) * | 1999-09-17 | 2001-10-16 | Depuy Orthopaedics | Endothelin-based compositions for enhancing connective tissue repair |
| US7186419B2 (en) * | 2000-08-25 | 2007-03-06 | Contura Sa | Polyacrylamide hydrogel for arthritis |
| MY130475A (en) * | 2000-08-25 | 2007-06-29 | Contura As | Polyacrylamide hydrogel and its use as an endoprosthesis |
| WO2002030481A1 (en) * | 2000-10-10 | 2002-04-18 | Massachusetts Institute Of Technology | Cell delivery using controllably degradable mesh-gel constructs |
| US7175336B2 (en) | 2001-01-26 | 2007-02-13 | Depuy Acromed, Inc. | Graft delivery system |
| US6723131B2 (en) | 2001-02-28 | 2004-04-20 | The Cleveland Clinic Foundation | Composite bone marrow graft material with method and kit |
| DE60228477D1 (en) * | 2001-05-08 | 2008-10-02 | Darwin Molecular Corp | PROCESS FOR REGULATING THE IMMUNE FUNCTION IN PRIMATES USING THE FOXP3 PROTEIN |
| WO2003018077A1 (en) * | 2001-08-22 | 2003-03-06 | National Institute Of Advanced Industrial Science And Technology | Method of bone regeneration |
| WO2003018641A1 (en) * | 2001-08-25 | 2003-03-06 | Contura Sa | Temperature-controlled process for preparation of homogeneous polymers |
| US7371409B2 (en) | 2001-09-06 | 2008-05-13 | Wright Medical Technology, Inc. | Bone graft substitute composition |
| EP1435980A4 (en) * | 2001-09-15 | 2006-06-07 | Univ California | Stratified cartilage tissue and methods to engineer same |
| US20030165473A1 (en) * | 2001-11-09 | 2003-09-04 | Rush-Presbyterian-St. Luke's Medical Center | Engineered intervertebral disc tissue |
| EP1499267A4 (en) * | 2002-02-05 | 2008-10-29 | Depuy Mitek Inc | Bioresorbable osteoconductive compositions for bone regeneration |
| AU2003224710A1 (en) * | 2002-03-18 | 2003-10-08 | Carnegie Mellon University | Method and apparatus for preparing biomimetic scaffold |
| US8529956B2 (en) | 2002-03-18 | 2013-09-10 | Carnell Therapeutics Corporation | Methods and apparatus for manufacturing plasma based plastics and bioplastics produced therefrom |
| US8293530B2 (en) * | 2006-10-17 | 2012-10-23 | Carnegie Mellon University | Method and apparatus for manufacturing plasma based plastics and bioplastics produced therefrom |
| ATE490745T1 (en) | 2002-03-29 | 2010-12-15 | Wright Medical Tech Inc | BONE TRANSPLANT REPLACEMENT COMPOSITION |
| US20060204544A1 (en) * | 2002-05-20 | 2006-09-14 | Musculoskeletal Transplant Foundation | Allograft bone composition having a gelatin binder |
| US8187326B2 (en) * | 2002-05-22 | 2012-05-29 | Advanced Technologies And Regenerative Medicine, Llc. | Attachment of absorbable tissue scaffolds to fixation devices |
| US6652887B1 (en) | 2002-06-24 | 2003-11-25 | Wright Medical Technology, Inc. | Bone graft substitute composition |
| US7291179B2 (en) * | 2002-06-24 | 2007-11-06 | Wright Medical Technology, Inc. | Bone graft substitute composition |
| US7745532B2 (en) * | 2002-08-02 | 2010-06-29 | Cambridge Polymer Group, Inc. | Systems and methods for controlling and forming polymer gels |
| WO2005017000A1 (en) * | 2003-07-31 | 2005-02-24 | Cambridge Polymer Group | Systems and methods for controlling and forming polymer gels |
| KR100539371B1 (en) * | 2002-10-21 | 2005-12-27 | 메디칸(주) | In vitro cultured human preadipocyte for human soft tissue volume replacement with injectable material as a scaffold |
| US7507257B2 (en) * | 2003-02-04 | 2009-03-24 | Wright Medical Technology, Inc. | Injectable resorbable bone graft material, powder for forming same and methods relating thereto for treating bone defects |
| AU2004229502C1 (en) | 2003-04-11 | 2011-02-24 | Etex Corporation | Osteoinductive bone material |
| US6905723B2 (en) * | 2003-05-30 | 2005-06-14 | Depuy Products, Inc. | Strontium-substituted apatite coating |
| US7067169B2 (en) * | 2003-06-04 | 2006-06-27 | Chemat Technology Inc. | Coated implants and methods of coating |
| US7375077B2 (en) * | 2003-09-19 | 2008-05-20 | The Board Of Trustees Of The University Of Illinois | In vivo synthesis of connective tissues |
| US7910124B2 (en) | 2004-02-06 | 2011-03-22 | Georgia Tech Research Corporation | Load bearing biocompatible device |
| EP1786485A4 (en) | 2004-02-06 | 2012-05-30 | Georgia Tech Res Inst | Surface directed cellular attachment |
| WO2005117919A2 (en) | 2004-04-15 | 2005-12-15 | Etex Corporation | Delayed-setting calcium phosphate pastes |
| US20050278025A1 (en) * | 2004-06-10 | 2005-12-15 | Salumedica Llc | Meniscus prosthesis |
| US8192759B2 (en) * | 2004-07-12 | 2012-06-05 | Isto Technologies, Inc. | Matrix made of polyester polymers entangled with hyaluronic polymers useful for supporting tissue repair |
| US8512730B2 (en) * | 2004-07-12 | 2013-08-20 | Isto Technologies, Inc. | Methods of tissue repair and compositions therefor |
| US7250550B2 (en) | 2004-10-22 | 2007-07-31 | Wright Medical Technology, Inc. | Synthetic bone substitute material |
| US9981063B2 (en) * | 2004-11-24 | 2018-05-29 | Mayo Foundation For Medical Education And Research | Biosynthetic composite for osteochondral defect repair |
| US20060293236A1 (en) * | 2005-06-23 | 2006-12-28 | Prescott Albert G | Injectable Osteogenic Formula and Method of Using Same |
| US8025903B2 (en) | 2005-09-09 | 2011-09-27 | Wright Medical Technology, Inc. | Composite bone graft substitute cement and articles produced therefrom |
| WO2007030616A2 (en) | 2005-09-09 | 2007-03-15 | Wright Medical Technology, Inc. | Composite bone graft substitute cement and articles produced therefrom |
| TWI274591B (en) * | 2005-11-07 | 2007-03-01 | Univ Tsinghua | Composite scaffold for remedying articular cartilage tissue and preparation thereof |
| EP1962914B1 (en) | 2005-11-14 | 2019-02-27 | Biomet 3i, LLC | Deposition of discrete nanoparticles on an implant surface |
| US8147860B2 (en) | 2005-12-06 | 2012-04-03 | Etex Corporation | Porous calcium phosphate bone material |
| EP1973554B1 (en) * | 2005-12-07 | 2015-01-14 | Isto Technologies Inc. | Cartilage repair methods |
| US20070184087A1 (en) * | 2006-02-06 | 2007-08-09 | Bioform Medical, Inc. | Polysaccharide compositions for use in tissue augmentation |
| US8529958B2 (en) | 2006-10-17 | 2013-09-10 | Carmell Therapeutics Corporation | Methods and apparatus for manufacturing plasma based plastics and bioplastics produced therefrom |
| US7935363B2 (en) | 2006-12-12 | 2011-05-03 | Synthasome, Inc. | Composite material for tissue repair |
| WO2008124494A1 (en) * | 2007-04-03 | 2008-10-16 | The Cleveland Clinic Foundation | Enrichment of tissue-derived adult stem cells based on retained extracellular matrix material |
| EP2211753A1 (en) | 2007-09-27 | 2010-08-04 | 3M Innovative Properties Company | Digitally forming a dental model for fabricating orthodontic laboratory appliances |
| EP2242441B1 (en) * | 2007-12-21 | 2019-01-23 | 3M Innovative Properties Company | Methods of preparing a virtual dentition model and fabricating a dental retainer therefrom |
| JP5806466B2 (en) | 2008-01-28 | 2015-11-10 | バイオメット・３アイ・エルエルシー | Implant surface with improved hydrophilicity |
| US8293813B2 (en) * | 2008-03-05 | 2012-10-23 | Biomet Manufacturing Corporation | Cohesive and compression resistant demineralized bone carrier matrix |
| DK2299926T3 (en) | 2008-06-26 | 2020-03-02 | 3M Innovative Properties Co | PROCEDURE FOR PREPARING A TRANSFER TRAY FOR ORTHODONTIC DEVICES |
| US20100055078A1 (en) * | 2008-08-15 | 2010-03-04 | The Government of the U.S.A, as represented by the Department of Veterans Affairs | Methods of making a transplantable bone repair system using multipotent stem cells |
| CN101347641A (en) * | 2008-09-04 | 2009-01-21 | 崔福斋 | Hydroxylapatite ceramic spinal fusion device |
| CN102695500A (en) | 2009-11-09 | 2012-09-26 | 聚光灯技术合伙有限责任公司 | Polysaccharide based hydrogels |
| NZ599527A (en) | 2009-11-09 | 2014-04-30 | Spotlight Technology Partners Llc | Fragmented hydrogels |
| US8641418B2 (en) | 2010-03-29 | 2014-02-04 | Biomet 3I, Llc | Titanium nano-scale etching on an implant surface |
| US8883210B1 (en) | 2010-05-14 | 2014-11-11 | Musculoskeletal Transplant Foundation | Tissue-derived tissuegenic implants, and methods of fabricating and using same |
| US10130736B1 (en) | 2010-05-14 | 2018-11-20 | Musculoskeletal Transplant Foundation | Tissue-derived tissuegenic implants, and methods of fabricating and using same |
| US9352003B1 (en) | 2010-05-14 | 2016-05-31 | Musculoskeletal Transplant Foundation | Tissue-derived tissuegenic implants, and methods of fabricating and using same |
| WO2012048275A2 (en) | 2010-10-08 | 2012-04-12 | Caridianbct, Inc. | Configurable methods and systems of growing and harvesting cells in a hollow fiber bioreactor system |
| EP2688514A1 (en) | 2011-03-21 | 2014-01-29 | Endo Pharmaceuticals Inc. | Urethral anastomosis device and method |
| US8834928B1 (en) | 2011-05-16 | 2014-09-16 | Musculoskeletal Transplant Foundation | Tissue-derived tissugenic implants, and methods of fabricating and using same |
| WO2012162552A1 (en) | 2011-05-26 | 2012-11-29 | Cartiva, Inc. | Tapered joint implant and related tools |
| ES2671740T3 (en) | 2012-03-20 | 2018-06-08 | Biomet 3I, Llc | Treatment surface for an implant surface |
| US10207027B2 (en) | 2012-06-11 | 2019-02-19 | Globus Medical, Inc. | Bioactive bone graft substitutes |
| US20150245839A1 (en) | 2012-09-18 | 2015-09-03 | Endo Pharmaceuticals Inc. | Urethral anastomosis device and method |
| US10245306B2 (en) | 2012-11-16 | 2019-04-02 | Isto Technologies Ii, Llc | Flexible tissue matrix and methods for joint repair |
| US8873041B1 (en) | 2013-01-29 | 2014-10-28 | Bayspec, Inc. | Raman spectroscopy using multiple excitation wavelengths |
| EP2967556A1 (en) | 2013-03-14 | 2016-01-20 | Endo Pharmaceuticals Inc. | Urethral anastomosis device |
| US9486483B2 (en) | 2013-10-18 | 2016-11-08 | Globus Medical, Inc. | Bone grafts including osteogenic stem cells, and methods relating to the same |
| US9539286B2 (en) | 2013-10-18 | 2017-01-10 | Globus Medical, Inc. | Bone grafts including osteogenic stem cells, and methods relating to the same |
| JP6633522B2 (en) | 2013-11-16 | 2020-01-22 | テルモ ビーシーティー、インコーポレーテッド | Cell growth in bioreactors |
| US9579421B2 (en) | 2014-02-07 | 2017-02-28 | Globus Medical Inc. | Bone grafts and methods of making and using bone grafts |
| US9463264B2 (en) | 2014-02-11 | 2016-10-11 | Globus Medical, Inc. | Bone grafts and methods of making and using bone grafts |
| WO2015148704A1 (en) | 2014-03-25 | 2015-10-01 | Terumo Bct, Inc. | Passive replacement of media |
| US9907882B2 (en) * | 2014-04-18 | 2018-03-06 | Warsaw Orthopedic, Inc. | Demineralized bone matrix with improved osteoinductivity |
| JP6830059B2 (en) | 2014-09-26 | 2021-02-17 | テルモ ビーシーティー、インコーポレーテッド | Scheduled cell feeding |
| US10179191B2 (en) | 2014-10-09 | 2019-01-15 | Isto Technologies Ii, Llc | Flexible tissue matrix and methods for joint repair |
| WO2016161025A1 (en) | 2015-03-31 | 2016-10-06 | Cartiva, Inc. | Hydrogel implants with porous materials and methods |
| EP3892241A1 (en) | 2015-03-31 | 2021-10-13 | Cartiva, Inc. | Drill bit for carpometacarpal implant |
| AU2016248062B2 (en) | 2015-04-14 | 2020-01-23 | Cartiva, Inc. | Tooling for creating tapered opening in tissue and related methods |
| WO2016187413A1 (en) | 2015-05-21 | 2016-11-24 | Musculoskeletal Transplant Foundation | Modified demineralized cortical bone fibers |
| US10016529B2 (en) | 2015-06-10 | 2018-07-10 | Globus Medical, Inc. | Biomaterial compositions, implants, and methods of making the same |
| US11426489B2 (en) | 2015-06-10 | 2022-08-30 | Globus Medical, Inc. | Biomaterial compositions, implants, and methods of making the same |
| WO2017004592A1 (en) | 2015-07-02 | 2017-01-05 | Terumo Bct, Inc. | Cell growth with mechanical stimuli |
| WO2017205667A1 (en) | 2016-05-25 | 2017-11-30 | Terumo Bct, Inc. | Cell expansion |
| US11685883B2 (en) | 2016-06-07 | 2023-06-27 | Terumo Bct, Inc. | Methods and systems for coating a cell growth surface |
| US11104874B2 (en) | 2016-06-07 | 2021-08-31 | Terumo Bct, Inc. | Coating a bioreactor |
| US11629332B2 (en) | 2017-03-31 | 2023-04-18 | Terumo Bct, Inc. | Cell expansion |
| US11624046B2 (en) | 2017-03-31 | 2023-04-11 | Terumo Bct, Inc. | Cell expansion |
| WO2021105878A1 (en) | 2019-11-26 | 2021-06-03 | 3M Innovative Properties Company | A dental template for direct bonding orthodontic appliances and methods of making and using the same |
| EP4138719A1 (en) | 2020-04-24 | 2023-03-01 | 3M Innovative Properties Company | An indirect bonding tray for bonding orthodontic appliances and methods of making and using the same |
| US11896736B2 (en) | 2020-07-13 | 2024-02-13 | Globus Medical, Inc | Biomaterial implants and methods of making the same |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL74617A (en) * | 1985-03-15 | 1988-11-15 | Yeda Res & Dev | Compositions comprising a vitamin d derivative and method for the local treatment of bone fractures in animals |
| US5171310A (en) * | 1989-07-17 | 1992-12-15 | Chisena Ernest C | Method and apparatus for treating fractures of long bones |
| US5197985A (en) * | 1990-11-16 | 1993-03-30 | Caplan Arnold I | Method for enhancing the implantation and differentiation of marrow-derived mesenchymal cells |
| US5486359A (en) * | 1990-11-16 | 1996-01-23 | Osiris Therapeutics, Inc. | Human mesenchymal stem cells |
| US5226914A (en) * | 1990-11-16 | 1993-07-13 | Caplan Arnold I | Method for treating connective tissue disorders |
| GB9125052D0 (en) * | 1991-11-26 | 1992-01-22 | Isis Innovation | Culture of bone cells |
| US5324294A (en) * | 1992-10-15 | 1994-06-28 | Dental Marketing Specialists | Bone augmentation method and apparatus |
| US5439951A (en) * | 1993-03-24 | 1995-08-08 | Children's Medical Center Corporation | Isolation of the calcium-phosphate crystals of bone |
| US5565502A (en) * | 1993-03-24 | 1996-10-15 | Children's Medical Center Corporation | Isolation of the calcium-phosphate crystals of bone |
| WO1994022463A1 (en) * | 1993-03-29 | 1994-10-13 | Zymogenetics, Inc. | Oesteoblast growth stimulating compostion containing pdgf and vitamin d |
| US5518680A (en) * | 1993-10-18 | 1996-05-21 | Massachusetts Institute Of Technology | Tissue regeneration matrices by solid free form fabrication techniques |
-
1995
- 1995-10-20 US US08/545,988 patent/US5700289A/en not_active Expired - Lifetime
-
1996
- 1996-10-17 EP EP96936643A patent/EP0862617A1/en not_active Withdrawn
- 1996-10-17 AU AU74515/96A patent/AU7451596A/en not_active Abandoned
- 1996-10-17 WO PCT/US1996/016664 patent/WO1997014783A1/en not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO1997014783B1 (en) | Tissue-engineered bone repair using cultured periosteal cells | |
| US5648301A (en) | Bioactive material template for in vitro synthesis of bone tissue | |
| Du et al. | Three‐dimensional nano‐HAp/collagen matrix loading with osteogenic cells in organ culture | |
| Kim et al. | Optimizing seeding and culture methods to engineer smooth muscle tissue on biodegradable polymer matrices | |
| US6413538B1 (en) | Bioactive glass or ceramic substrates having bound cell adhesion molecules | |
| AU2009212946B2 (en) | Autologous cells on a support matrix for tissue repair | |
| Ecarot-Charrier et al. | Mineralization in osteoblast cultures: a light and electron microscopic study | |
| De Bruijn et al. | Osteoclastic resorption of calcium phosphates is potentiated in postosteogenic culture conditions | |
| Ducheyne et al. | Effect of bioadctive glass templates on osteoblast proliferation and in vitro synthesis of bone‐like tissue | |
| Vehof et al. | Influence of rhBMP-2 on rat bone marrow stromal cells cultured on titanium fiber mesh | |
| CA2557436A1 (en) | Polymer-ceramic-hydrogel composite scaffold for osteochondral repair | |
| KR20000057136A (en) | Application of shear flow stress to chondrocytes | |
| Kaufmann et al. | Effect of varying physical properties of porous, surface modified bioactive glass 45S5 on osteoblast proliferation and maturation | |
| Fricain et al. | Evaluation of proliferation and protein expression of human bone marrow cells cultured on coral crystallized in the aragonite or calcite form | |
| Weissenböck et al. | Particle size of hydroxyapatite granules calcified from red algae affects the osteogenic potential of human mesenchymal stem cells in vitro | |
| EP1819290A4 (en) | Scaffoldless constructs for tissue engineering of articular cartilage | |
| Masquelier et al. | Morphologic characterization of osteoblast-like cell cultures isolated from newborn rat calvaria | |
| Robey | Cell-mediated calcification in vitro | |
| Faucheux et al. | Biocompatibility testing of a bovine hydroxy—apatite ceramic material with the use of osteo-progenitor cells isolated from human bone marrow | |
| Petite et al. | Adhesion, growth and differentiation of human bone marrow stromal cells on non-porous calcium carbonate and plastic substrata: effects of dexamethasone and 1, 25dihydroxyvitamin D3 | |
| Stanton et al. | The growth of chondrocytes using Gelfoam® as a biodegradable scaffold | |
| Srouji et al. | Microscopy analysis of bone marrow–derived osteoprogenitor cells cultured on hydrogel 3‐D scaffold | |
| JP2001523447A (en) | Method for inducing osteoblast differentiation of human extramedullary adipose tissue cells | |
| DE69531627T2 (en) | HUMANE HYPERTROPHE CHRONDROCYTE CELL LINES | |
| Hosseini et al. | Collagen fibres are not required for initial matrix mineralization by bone cells |